702 - 703 |
Untitled Redakcji O |
705 - 711 |
Interview with M. Eng Janusz Obukowicz, manager of the pharmaceutical institute in Warsaw [Anonymous] |
712 - 715 |
History of pharmaceutical institute. Thoughts of a long-term director Szelejewski W |
724 - 726 |
Analytical Method Transfer. Necessary evil or parodoxical savings of costs? Kosmacinska B, Zielinska A, Maruszak W, Kamienska-Duda A, Drazkowiak A, Beczkowiz H |
726 - 726 |
Deliberations on topic of "Listy 500" for year 2006. Rzeczpospolita supplement of the "Listy 500", 25 April, 2007 Krawczyk Z |
743 - 746 |
The improvements in the synthesis of ACE inhibitors. Preparation of trandolapril, ramipril and quinapril Bankowski K |
747 - 750 |
Validation of HPLC method used for control of cleaning procedure during the pharmaceutical substance manufacturing Baran PA, Bielejewska A, Glice MM, Beczkowicz H, Maruszak W, Kosmacinska B, Golebiewski P |
751 - 755 |
Optimization conditions of residual solvents determination by gas chromatography in active pharmaceutical ingredients Biernat J, Goleliewski P, Groman A |
756 - 759 |
Polymorphism of rosiglitazone maleate. Facts and myths Chodynski M, Fitak H, Glice MM, Korczak K, Leszczynska K, Kutner A |
760 - 763 |
Modification of a new for method manufacturing cakipotriol Chodynski M, Fitak H, Leszczynska K, Zochowski J, Kutner A |
764 - 767 |
Synthesis of ligands with mixed 5-HT1A and 5-HT2A receptor profile Cybulski M |
768 - 772 |
Application of IR method for process control in synthesis of "floxacinic acid" ester, a key intermediate in manufacturing third generation fluoroquinolonic anlibiotics Glice MM, Badowska-Roslonek K, Kaczmarek L |
773 - 776 |
Simple synthesis of aripiprazole API in desired polymorphk form Kaczmarek L, Badowska-Roslonek K, Laszcz M |
777 - 779 |
Use of NMR technique to study the photoizomerization in triene unit Kubiszewski M, Krajewski K |
780 - 782 |
Packaging materials in pharmaceutical industry. A pharmacopeal approach. Use of DSC and IR techniques for testing the plastic packaging materials Laszcz M, Baranowska B, Kasprzak P, Kubiszewski M |
783 - 788 |
A novel synthesis of antineoplastic drug docetaxel Michalak O, Bankowski K, Achmatowicz O |
789 - 792 |
The matrix effect on LC-MS bioanalysis of drugs and their metabolites Rudzki PJ, Bus KM, Ksycinska H, Kobylinska K |
793 - 796 |
Methods for isolation of drugs from biological material Sarosiek A, Szlagowska A, Kobylinska K |
797 - 799 |
Perspectives of nanotechnology in medicine and pharmacy and its influence on pharmaceutical industry Stolarczyka EU, Stolarczyk K |
800 - 803 |
The newest developments in impurity profiling by mass spectrometry Stolarczyk EU |